Powered by

Avita Announces Receipt of $975K R&D Tax Incentive

Mar 15, 2017 - Business Wire

Avita Medical Limited (ASX: AVH ) (OTCQX: AVMXY ), a regenerative medicine company focused on the treatment of wounds and skin defects, today announced that it has received a Research and Development Tax Incentive cash rebate from the Australian Tax Office of A$974,908 for the financial year ending 30 June 2016. The R&D Tax Incentive provides a tax cash rebate to support Australian companies undertaking research and development projects.

"The receipt of the non-dilutive payment resulting f...